Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

6.

Role of PAC(1) receptor in adrenal catecholamine secretion induced by PACAP and VIP in vivo.

Lamouche S, Yamaguchi N.

Am J Physiol Regul Integr Comp Physiol. 2001 Feb;280(2):R510-8.

7.

Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on adenohypophyseal Hormone secretion in normal men.

Chiodera P, Volpi R, Capretti L, Caffarri G, Magotti MG, Coiro V.

Neuroendocrinology. 1996 Sep;64(3):242-6.

PMID:
8875442
8.
9.

Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.

Tachibana T, Saito ES, Takahashi H, Saito S, Tomonaga S, Boswell T, Furuse M.

Regul Pept. 2004 Aug 15;120(1-3):99-105.

PMID:
15177926
11.
12.
13.

Increase of prolactin mRNA in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP.

Bredow S, Kacsóh B, Obál F Jr, Fang J, Krueger JM.

Brain Res. 1994 Oct 17;660(2):301-8.

PMID:
7820699
14.
16.

Intracerebroventricular injection of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibits feeding in chicks.

Tachibana T, Saito S, Tomonaga S, Takagi T, Saito ES, Boswell T, Furuse M.

Neurosci Lett. 2003 Mar 27;339(3):203-6.

PMID:
12633888
17.

Roles and mechanisms of action of pituitary adenylate cyclase-activating polypeptide (PACAP) in growth hormone and prolactin secretion.

Murakami Y, Koshimura K, Yamauchi K, Nishiki M, Tanaka J, Kato Y.

Endocr J. 2001 Apr;48(2):123-32. Review.

18.
20.

Effect of pituitary adenylate cyclase-activating polypeptide 38 on growth hormone and prolactin expression.

Velkeniers B, Zheng L, Kazemzadeh M, Robberecht P, Vanhaelst L, Hooghe-Peters EL.

J Endocrinol. 1994 Oct;143(1):1-11.

PMID:
7964308
Items per page

Supplemental Content

Support Center